Straight to content

Post-trial access to treatment

Corporate best practices

Posted in category:
Publication
Written by:
Written by: Irene Schipper
Published on:

The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and corporate best practices relating to the provision of PTA in low and middle income countries based on company sources. In these countries there is a greater appeal for pharmaceutical companies to take responsibility for providing PTA. However, the practice of providing PTA is the exception rather than the rule.

Do you need more information?

Publication

Posted in category:
Publication
Written by:
Written by: Irene Schipper
Published on:

Related content

Don't want to miss anything?

Sign up for our newsletter and always stay up to date on information and analysis on corporate power issues.